Literature DB >> 24965450

Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.

Frederik Graw1, Roland R Regoes2.   

Abstract

UNLABELLED: During the chronic phase of HIV-1 infection, polyfunctional CD8+ T cell responses, which are characterized by a high frequency of cells able to secrete multiple cytokines simultaneously, are associated with lower virus loads and slower disease progression. This relationship may arise for different reasons. Polyfunctional responses may simply be stronger. Alternatively, it could be that the increased functional diversity in polyfunctional responses leads to lower virus loads and slower disease progression. Lastly, polyfunctional responses could contain more CD8+ T cells that mediate a specific key function that is primarily responsible for viral control. Disentangling the influences of overall strength, functional diversity, and specific function on viral control and disease progression is very relevant for the rational design of vaccines and immunotherapy using cellular immune responses. We developed a mathematical model to study how polyfunctional CD8+ T cell responses mediating lytic and nonlytic effector functions affect the CD4+ T cell count and plasma viral load. We based our model on in vitro data on the efficacy of gamma interferon (IFN-γ) and macrophage inflammatory protein 1β (MIP-1β)/RANTES against HIV. We find that the strength of the response is a good predictor of disease progression, while functional diversity has only a minor influence. In addition, our model predicts for realistic levels of cytotoxicity that immune responses dominated by nonlytic effector functions most positively influence disease outcome. IMPORTANCE: It is an open question in HIV research why polyfunctional CD8+ T cell responses are associated with better viral control, while individual functional correlates of protection have not been identified so far. Identifying the role of CD8+ T cells in HIV-1 infection has important implications for the potential development of effective T cell-based vaccines. Our analysis provides new ways to think about a causative role of CD8+ T cells by studying different hypotheses regarding why polyfunctional CD8+ T cells might be more advantageous. We identify measurements that have to be obtained in order to evaluate the role of CD8+ T cells in HIV-1 infection. In addition, our method shows how individual cell functionality data can be used in population-based virus dynamics models.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24965450      PMCID: PMC4136339          DOI: 10.1128/JVI.00647-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.

Authors:  Patricia A Darrah; Dipti T Patel; Paula M De Luca; Ross W B Lindsay; Dylan F Davey; Barbara J Flynn; Søren T Hoff; Peter Andersen; Steven G Reed; Sheldon L Morris; Mario Roederer; Robert A Seder
Journal:  Nat Med       Date:  2007-06-10       Impact factor: 53.440

Review 2.  T-cell quality in memory and protection: implications for vaccine design.

Authors:  Robert A Seder; Patricia A Darrah; Mario Roederer
Journal:  Nat Rev Immunol       Date:  2008-03-07       Impact factor: 53.106

Review 3.  Many cytokines are very useful therapeutic targets in disease.

Authors:  Marc Feldmann
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

4.  Gamma interferon responses of CD4 and CD8 T-cell subsets are quantitatively different and independent of each other during pulmonary Mycobacterium bovis BCG infection.

Authors:  Patricia Ngai; Sarah McCormick; Cherrie Small; Xizhong Zhang; Anna Zganiacz; Naoko Aoki; Zhou Xing
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

5.  Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques.

Authors:  Hannah Yuan Chen; Michele Di Mascio; Alan S Perelson; David D Ho; Linqi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

Review 6.  CD8 T cell dysfunction during chronic viral infection.

Authors:  Haina Shin; E John Wherry
Journal:  Curr Opin Immunol       Date:  2007-07-25       Impact factor: 7.486

7.  Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells.

Authors:  Sunil Kannanganat; Chris Ibegbu; Lakshmi Chennareddi; Harriet L Robinson; Rama Rao Amara
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

8.  Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy.

Authors:  Manuela Rehr; Julia Cahenzli; Anna Haas; David A Price; Emma Gostick; Milo Huber; Urs Karrer; Annette Oxenius
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

9.  Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time.

Authors:  Ingrid M M Schellens; José A M Borghans; Christine A Jansen; Iris M De Cuyper; Ronald B Geskus; Debbie van Baarle; Frank Miedema
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

10.  Dynamics of immune escape during HIV/SIV infection.

Authors:  Christian L Althaus; Rob J De Boer
Journal:  PLoS Comput Biol       Date:  2008-07-18       Impact factor: 4.475

View more
  11 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

2.  Lipophagy confers a key metabolic advantage that ensures protective CD8A T-cell responses against HIV-1.

Authors:  Hamza Loucif; Xavier Dagenais-Lussier; Cherifa Beji; Léna Cassin; Hani Jrade; Roman Tellitchenko; Jean-Pierre Routy; David Olagnier; Julien van Grevenynghe
Journal:  Autophagy       Date:  2021-01-18       Impact factor: 16.016

3.  Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.

Authors:  Maria L Knudsen; Karl Ljungberg; Roger Tatoud; Jonathan Weber; Mariano Esteban; Peter Liljeström
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

4.  Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection.

Authors:  Anders Boyd; Jorge R Almeida; Patricia A Darrah; Delphine Sauce; Robert A Seder; Victor Appay; Guy Gorochov; Martin Larsen
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

Review 5.  Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.

Authors:  Elena Gonzalo-Gil; Uchenna Ikediobi; Richard E Sutton
Journal:  Yale J Biol Med       Date:  2017-06-23

6.  Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.

Authors:  Sivasankaran Munusamy Ponnan; Sathyamurthy Pattabiram; Kannan Thiruvengadam; Rajat Goyal; Nikhil Singla; Joyeeta Mukherjee; Shweta Chatrath; Philip Bergin; Jakub T Kopycinski; Jill Gilmour; Sriram Kumar; Malathy Muthu; Sudha Subramaniam; Soumya Swaminathan; Srikanth Prasad Tripathy; Hanna Elizabeth Luke
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

7.  Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.

Authors:  Alba Ruiz; Oscar Blanch-Lombarte; Esther Jimenez-Moyano; Dan Ouchi; Beatriz Mothe; Ruth Peña; Cristina Galvez; Meritxell Genescà; Javier Martinez-Picado; Philip Goulder; Richard Barnard; Bonnie Howell; Bonaventura Clotet; Julia G Prado
Journal:  Front Immunol       Date:  2019-01-22       Impact factor: 7.561

8.  Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus.

Authors:  Rosana Domingues; Gabriel Costa de Carvalho; Valéria Aoki; Alberto José da Silva Duarte; Maria Notomi Sato
Journal:  J Transl Med       Date:  2016-06-10       Impact factor: 5.531

9.  Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.

Authors:  Ornella Franzese; Belinda Palermo; Cosmo Di Donna; Isabella Sperduti; Virginia Ferraresi; Helena Stabile; Angela Gismondi; Angela Santoni; Paola Nisticò
Journal:  Oncoimmunology       Date:  2016-02-01       Impact factor: 8.110

10.  A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.

Authors:  D Ruane; Y Do; L Brane; A Garg; L Bozzacco; T Kraus; M Caskey; A Salazar; C Trumpheller; S Mehandru
Journal:  Mucosal Immunol       Date:  2016-01-06       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.